Silvia Taylor | Senior Vice President, Corporate Affairs and Investor Relations |
Stan Erck | President and Chief Executive Officer |
Filip Dubovsky | Chief Medical Officer |
John Trizzino | Chief Commercial Officer, Chief Business Officer and Interim Chief Financial Officer |
Greg Glenn | President of R&D |
Kelechi Chikere | Jefferies |
Mayank Mamtani | B. Riley FBR |
Charles Duncan | Cantor Fitzgerald |
Vernon Bernardino | H. C. Wainwright |
Eric Joseph | JPMorgan |
Good day, everyone, and welcome to the Novavax Second Quarter 2021 Financial and Operating Results. All participants will be in a listen-only mode. [Operator Instructions] After today’s presentation, there will be an opportunity to ask questions. [Operator Instructions] Please note that this event is being recorded. I would now like to turn the conference over to Silvia Taylor, Senior Vice President, Corporate Affairs and Investor Relations.